Juncture Wealth Strategies’s PTC Therapeutics PTCT Stock Holding History

Juncture Wealth Strategies’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$634K	Sell	9,793 -784	-7%	-$57.1K	0.16%	94
2026 Q2	$863K	Buy	10,577 +5,429	+105%	+$392K	0.22%	71
2026 Q1	$351K	Buy	5,148 +475	+10%	+$33.6K	0.12%	95
2025 Q4	$355K	Buy	4,673 +571	+14%	+$41.5K	0.12%	92
2025 Q3	$252K	Buy	+4,102	New	+$214K	0.08%	116

Other funds holding PTCT

PCA

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Sacks & Associates Warren, New Jersey $143M AUM 17.48% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

DCM

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Juncture Wealth Strategies's PTCT Position: Q3 2026 in Review

Juncture Wealth Strategies reduced its PTC Therapeutics (PTCT) stake by 7.4% in Q3 2026, selling an estimated $57.1K and leaving 9,793 shares worth $634K. The position accounts for 0.16% of the portfolio, ranked #94.

Juncture Wealth Strategies first reported a position in PTCT in Q3 2025 and has held it in 5 quarters since. The position peaked at $863K in Q2 2026. 8 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

Juncture Wealth Strategies held 9,793 shares of PTC Therapeutics worth $634K as of Q3 2026.
Juncture Wealth Strategies sold 784 PTC Therapeutics shares in Q3 2026, an estimated $57.1K.
PTC Therapeutics made up 0.16% of Juncture Wealth Strategies's portfolio in Q3 2026, its #94 holding.
Juncture Wealth Strategies first reported a position in PTC Therapeutics in Q3 2025 and has held it in 5 quarters since.
Juncture Wealth Strategies's PTC Therapeutics position peaked at $863K in Q2 2026.
8 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on Juncture Wealth Strategies's 13F filing for Q3 2026, filed 6 Oct 2026.